Effect of antiepileptic drugs on bone density in ambulatory patients

Neurology

Volumn 58, Issue 9, 2002, Pages 1348-1353

  Farhat, G ^a   Yamout, B ^a   Mikati, M A ^a   Demirjian, S ^a   Sawaya, R ^a   El Hajj Fuleihan, Ghada ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; BONE DENSITY; BONE METABOLISM; CALCIUM ABSORPTION; CALCIUM INTAKE; CALCIUM METABOLISM; CHILD; DRUG EFFECT; ENZYME INDUCTION; EPILEPSY; FEMALE; HUMAN; INSTITUTIONALIZATION; MAJOR CLINICAL STUDY; MALE; MICROSOME MEMBRANE; MINERAL METABOLISM; PRIORITY JOURNAL;

EID: 0037076461     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.9.1348     Document Type: Article

References (32)

1. Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children
2. Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy
3. Disturbance of calcium metabolism by anticonvulsant drugs
4. Incidence of anticonvulsant osteomalacia and effect of vitamin D: Controlled therapeutic trial
5. Phenobarbital-induced alterations in vitamin D metabolism
6. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment
7. Diphenylhydantoin: Direct inhibition of the vitamin D3-mediated calcium absorptive mechanism in organ-cultured duodenum
8. The interrelationships between serum 25-hydroxycholcalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia
9. Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy
10. Effect of carbamazepine and valproate on bone mineral density
11. Evaluation of bone mineral density in children receiving antiepileptic drugs
12. Bone density and antiepileptic drugs: A case-controlled study
13. Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: A quantitative digital radiographic study
14. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12
15. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy
16. Bone mineral density measured by dual energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs
17. Secondary hyperparathyroidism in the elderly: Means to defining hypovitaminosis D
18. Reproducibility of DXA densitometry: A model for bone loss estimates
19. The diagnosis of osteoporosis
20. Early development of intractable epilepsy in children: A prospective study
21. Optimal calcium intake. NIH consensus development panel on optimal calcium intake
22. Long-term anticonvulsant therapy and vitamin D metabolism in ambulatory pubertal children
23. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy
24. Skeletal status of women with epilepsy
25. Hypovitaminosis D in healthy school children
26. Hypovitaminosis D in a sunny country
27. Long-term anticonvulsant therapy leads to low bone mineral density: Evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells
28. Glucocorticoid-induced osteoporosis: Pathogenesis and management
29. Strategies to protect bone mass in the older patients with epilepsy
30. Guidelines are needed for treating diseases of bone metabolism in epilepsy
31. Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy
32. Anticonvulsant-induced bone disease. A plea for monitoring and treatment